| US Strategy Weekly (8 June 2026) - Strong Nonfarm Payrolls and AI Volatility Drive Risk Repricing as U.S. Equities Consolidate at Elevated Levels | Taylor, Ren Wen Fang | 2026-06-08 |
| 美股市场周报(2026/6/8) - 非农超预期与AI波动共振，美股高位震荡中重估风险 | 任闻放 | 2026-06-08 |
| 招商证券（国际）早会纪要 20260608 | 招商香港研究部 | 2026-06-08 |
| 招商证券（国际）早会纪要 20260605 | 招商香港研究部 | 2026-06-05 |
| 中国生物医药 - 解析行业分歧，逢低布局机遇 | 陈铸鸿,谭震,陈泓道 | 2026-06-04 |
| China Biopharma - Dissecting sector debates and navigating opportunity | Chen Zhuhong, Jonah,Tan Zhen,Chen Hongdao, George | 2026-06-04 |
| 招商证券（国际）早会纪要 20260604 | 招商香港研究部 | 2026-06-04 |
| SpaceX (SPCX US) - Space dominance, tested by AI ambition | Wong Tang Kit, Tommy,Li Yishan, Crystal,Zhang Henan | 2026-06-03 |
| SpaceX (SPCX US) - 航天主导优势，备受AI考验 | 王腾杰,李怡珊,张贺楠 | 2026-06-03 |
| Auto & Robotics - Auto Channel Checks: Brand Divergence Widens, Blockbuster Models in Focus | Liang Yonghuo | 2026-06-03 |
| 招商证券（国际）早会纪要 20260603 | 招商香港研究部 | 2026-06-03 |
| Phancy Group (6682 HK, NR) - 1Q26 reaffirmed strong growth trend; platform transformation accelerates to build differentiated advantages | Li Yishan, Crystal,Wong Tang Kit, Tommy,Zhang Henan | 2026-06-02 |
| MEITUAN (3690 HK, BUY) - Positive loss reduction trend reaffirmed | Li Yishan, Crystal,Wong Tang Kit, Tommy,Zhang Henan | 2026-06-02 |
| 招商证券（国际）早会纪要 20260602 | 招商香港研究部 | 2026-06-02 |
| 美股市场周报(2026/6/1) - 通胀未退，AI兑现：美股高位震荡中的结构支撑 | 任闻放 | 2026-06-01 |
| US Strategy Weekly (1 June 2026) - Inflation Persists, AI Delivers: Structural Support Behind U.S. Stocks’ High-Level Consolidation | Taylor, Ren Wen Fang | 2026-06-01 |
| HK Strategy Weekly (1 June 2026) - Uneven Economic Recovery, Hong Kong Equities Await Stronger Catalysts | Taylor, Ren Wen Fang | 2026-06-01 |
| 港股市场周报 (2026/6/1) - 经济修复分化，港股等待更强催化 | 任闻放 | 2026-06-01 |
| 招商证券（国际）早会纪要 20260601 | 招商香港研究部 | 2026-06-01 |
| 欧莱雅 (OREP FR) - 负重前行 | 黄铭谦,张力丹 | 2026-05-29 |